DRG’s extended worldwide coverage is the first and only evidence-based data set of epidemiological forecasts for key MDS patient populations covering 171 countries and more than 99% of the…
DRG Epidemiology’s coverage of myelodysplastic syndromes comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence of…
November 2, 2015
March 28, 2014